A Taxing Quarter for Bristol-Myers Squibb: Fool by Numbers

On July 28, Bristol-Myers Squibb (NYSE: BMY  ) released earnings for its 2005 second quarter, which ended June 30.

• Excluding special items, earnings per share were $0.47, easily besting Street estimates. That's a big improvement over last year.
• Net income was aided by $294 million in tax benefits, giving Bristol-Myers an effective tax rate of -1.9% during the quarter.

(Figures in millions, except per-share data)

Income Statement Highlights(What's this?)

Margin Checkup(What's this?)

Balance Sheet Highlights(What's this?)

No balance sheet data provided. (Boo!)

Cash Flow Highlights(What's this?)

No cash flow statement provided. (Hiss!)

Related Companies:

• ImClone Systems (Nasdaq: IMCL  )
• Merck (NYSE: MRK  )
• Novartis (NYSE: NVS  )
• Pfizer (NYSE: PFE  )
• Sanofi-Aventis (NYSE: SNY  )
• Schering-Plough (NYSE: SGP  )

Related Foolishness:

• Do you have the patience to invest in Bristol-Myers Squibb?
• It could be a good bet. The Feds let the company off cheap.
• At least Bristol-Myers got some headache relief in January.

You don't have to be a Rule Breaker to earn big returns in the pharmaceutical sector. Pfizer has been a winning pick for Philip Durell and subscribers to hisMotley Fool Inside Valuestock-picking service. See what the fuss is all about by taking a30-day risk-free trialtoday.

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so checkFool.comfor more of our in-depth discussion of what the numbers mean.

Fool contributorTim Beyersdidn't own stock in any of the companies mentioned in this story at the time of publication. You can find out what's in his portfolio by checking Tim's Fool profilehere. The Motley Fool has an ironcladdisclosure policy.